Clinical trial shows immunotherapy drug pembrolizumab improves outcomes for patients with soft tissue sarcoma
Credit: CC0 Public Domain Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue...
Read moreDetails